Social Media: Ignorance Not Bliss For Pharma, DIA Panelists Say
Executive Summary
Drugmakers must start monitoring adverse event data and product discussions on the Internet or run the risk of facing legal scrutiny, marketing specialists said at a Feb. 25 Drug Information Association conference in New York City
You may also be interested in...
Internet Ad Regulation: Industry Seeks To Develop Alternate Framework
Some members of the pharmaceutical industry are developing an alternate framework for regulation of the Internet to propose to FDA after the agency's citation of sponsored search results
Internet Ad Regulation: Industry Seeks To Develop Alternate Framework
Some members of the pharmaceutical industry are developing an alternate framework for regulation of the Internet to propose to FDA after the agency's citation of sponsored search results
Key To Drug Marketing: Evolve, Evolve, Evolve
Drug companies looking to maintain successful marketing platforms in the social media age must change messages with the technology.